Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer
- PMID: 37058164
- DOI: 10.1007/s00520-023-07736-0
Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer
Abstract
Purpose: Little is known about whether baseline health-related quality of life (HRQoL) scores also could predict occurrence radiotherapy-related toxicities, which we aim to assess in this study.
Methods: This study analyzed data from 200 patients enrolled in randomized study investigating the utility of HRQoL. HRQOL was assessed at baseline and during follow up using QLQ-C30 questionnaire and major toxicity was considered as adverse event ≥ 3 according to NCI-CTCAE classification. Cox regressions adjusting for clinical and sociodemographic data were used to assess prognostic significance of HRQOL scores.
Results: In multivariable analyses adjusted on clinical and sociodemographic data, every 10-point improvement in physical (HR = 0.74), role (HR = 0.87) and social (HR = 0.88) functioning was associated with 24%, 13% and 12% lower hazard of occurrence of major toxicity respectively while every 10 point-increase in dyspnea (HR = and loss appetite was associated with 15% and 16% increased hazard of major toxicity.
Conclusion: Certain baseline HRQoL scores were found to be significantly associated with the occurrence of major toxicity.
Keywords: Head and neck cancer; Health related quality of life; Predictive factors.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
Comment on: Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.Support Care Cancer. 2023 Oct 24;31(12):651. doi: 10.1007/s00520-023-08127-1. Support Care Cancer. 2023. PMID: 37874385 No abstract available.
References
-
- Lo Nigro C, Denaro N, Merlotti A, Merlano M (2017) Head and neck cancer: improving outcomes with a multidisciplinary approach. Cancer Manag Res 9:363–71. https://doi.org/10.2147/CMAR.S115761 - DOI - PubMed - PMC
-
- Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C (2015) Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 33(29):3235–42. https://doi.org/10.1200/JCO.2015.61.6995 - DOI
-
- Vokes EE, Agrawal N, Seiwert TY (2015) HPV-associated head and neck cancer. J Natl Cancer Inst 107(12):djv344. https://doi.org/10.1093/jnci/djv344 - DOI - PubMed
-
- Shah JP, Gil Z (2009) current concepts in management of oral cancer – surgery. Oral Oncol 45:394–401. https://doi.org/10.1016/j.oraloncology.2008.05.017 - DOI - PubMed
-
- Marur S, Forastiere AA (2016) Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 91(3):386–396. https://doi.org/10.1016/j.mayocp.2015.12.017 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical